Fenway Community Health Realty Corporation

Overview

Mission

To support the services of fenway community health center.

What it reported doing in 2024

Leased real property to fenway community health center, inc.

Operating model

Revenue model
No positive adjusted resources. The filing reports no positive adjusted operating resources.
Distribution model
Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.

Nonprofit profile at a glance

EIN
205413687
IRS 990 coverage
2009–2024
Forms available
Form 990 2024
Headquarters
Boston, MA, USA
Phone
6172670900
Rating confidence
Limited

The verdict

- This form does not report enough financial and governance detail to rate the organization. That is normal for this form and is not a warning sign.

Rating breakdown

  • Financial Efficiency: 36
  • Transparency & Controls: 93
  • Accountability: 91
  • Sustainability: 19
  • Growth: 40

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: Limited
  • Program expense ratio: 47.8%; rating input score 48
  • Fundraising efficiency: Limited

Transparency & Controls

  • Consistency checks: 100%; rating input score 100; 63rd percentile among comparable filings
  • Pay-setting controls: 6 of 6 controls in place; rating input score 100
    • Compensation committee: Pass
    • Independent consultant: Pass
    • Other Form 990s reviewed: Pass
    • Written employment contract: Pass
    • Compensation survey or study: Pass
    • Board or committee approval: Pass
  • Foreign activity oversight: Limited
  • Grant itemization coverage: Limited
  • Major donor itemization: Limited
  • Related-party transparency: Limited

Accountability

  • Independent voting board: 100%; rating input score 100; 64th percentile among comparable filings
  • Governance controls: 7 of 9 controls in place; rating input score 78
    • Conflict-of-interest policy: Pass
    • Whistleblower policy: Pass
    • Document-retention policy: Pass
    • CEO compensation review process: Fail
    • Other executive compensation review process: Fail
    • Form 990 shared with the board: Pass
    • Board meeting minutes documented: Pass
    • Audit committee oversight: Pass
    • Independent financial-statement audit: Pass

Sustainability

  • Operating margin: Limited
  • Total-asset coverage ratio: 7.31; rating input score 57; 57th percentile among comparable filings
  • Liabilities to assets ratio: 1.36; rating input score 4; 4th percentile among comparable filings
  • Officer compensation ratio: 4.3%; rating input score 18; 18th percentile among comparable filings

Growth

  • Program expense growth: 1.2% per year; rating input score 100; 55th percentile among comparable filings
  • Revenue growth: -5.6% per year; rating input score 0; 41st percentile among comparable filings
  • Asset growth: -2.1% per year; rating input score 0; 30th percentile among comparable filings

Details

  • Where the money goes: 47.8% of spending went to programs
  • Governance: 5 of 5 board members independent · 7 of 9 filing controls reported
  • Programs: 1 filed program accomplishment · $1.5M in reported program spending
  • Leadership: top reported pay $508K · 15 people listed · 6 of 6 pay-setting controls reported
  • Consistency: 18 of 18 current checks pass
  • Schedules: 5 filed schedules · includes executive pay
  • Filing history: 16 annual filings from 2009 to 2024
  • Contacts: How to reach this organization
  • Related organizations: 1 filed related-organization link
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Leadership & pay

15 people listed

Highest reported compensation

  • JORDINA SHANKS (CEO): $507,948 total reported compensation
  • PAYAL SRINIVASA (MED. DIR. SEXUAL & REPRODUCTIVE HEALTH): $371,779 total reported compensation
  • AMI MULTANI (DIR. INFECTIOUS DISEASES, HIV, & ANAL DYSPLASIA): $366,727 total reported compensation

Source: IRS Form 990. Selected filing: FY2024.